Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,18 USD | -1,67% | -4,84% | +11,27% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 19,21 mln. 17,96 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -9 mln. -8,41 mln. | Nettowinst (verlies) 2025 * | - | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-2
x | K/w-verhouding 2025 * |
-
| Werknemers | 1 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 95,61% |
Recentste transcriptie over Alaunos Therapeutics, Inc.
1 dag | -1,67% | ||
1 week | -4,84% | ||
Lopende maand | -34,81% | ||
1 maand | -38,22% | ||
3 maanden | -57,50% | ||
6 maanden | -21,49% | ||
Lopend jaar | +11,27% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Dale Hogue
CEO | Chief Executive Officer | 54 | 29/12 |
Director of Finance/CFO | 62 | 17-02-21 | |
Chief Tech/Sci/R&D Officer | 44 | 04-08-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jaime Vieser
BRD | Director/Board Member | 54 | 16-12-20 |
Holger Weis
CHM | Chairman | 61 | 16-12-20 |
Robert Postma
BRD | Director/Board Member | 70 | 05-02-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.04% | 0 M€ | 0,00% | - | |
0.01% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-04-24 | 1,18 | -1,67% | 30 372 |
23-04-24 | 1,2 | +10,09% | 46 815 |
22-04-24 | 1,09 | -2,68% | 38 305 |
19-04-24 | 1,12 | -8,94% | 49 732 |
18-04-24 | 1,23 | -0,81% | 33 088 |
uitgestelde koers Nasdaq, 24 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,27% | 19,21 mln. | |
-1,51% | 105 mld. | |
+3,22% | 97,5 mld. | |
+1,86% | 22,19 mld. | |
-16,53% | 21,33 mld. | |
-8,49% | 18,68 mld. | |
-42,33% | 16,6 mld. | |
-20,09% | 14,52 mld. | |
+5,47% | 14,09 mld. | |
+28,85% | 10,99 mld. |